Current Issue
Commentary
PD-L1 as a Novel Mediator of Lung Fibroblast to Myofibroblast Transition
J Cell Immunol, 2022, 4, 141 - 144
Xia Guo, Guoqing Qian
[DOI No.: https://doi.org/10.33696/immunology.4.142]
Review Article
Persistence, Pathogenicity and Plasticity: The Role of IL-23 in Th17 Fate
J Cell Immunol, 2022, 4, 121 - 130
Jens C. Kleiner, Christian F. Krebs
[DOI No.: https://doi.org/10.33696/immunology.4.140]
Commentary
CAR Therapy for T-cell Malignancies
J Cell Immunol, 2022, 4, 131 - 133
Andrew Cinquina, Jia Feng, Hongyu Zhang, Yupo Ma
[DOI No.: https://doi.org/10.33696/immunology.4.141]
Letter to Editor
Improvement of the Specificity of the Indirect BAT for the Diagnosis of Peanut Allergy; the BA(Blocking Antibodies)-BAT
J Cell Immunol, 2022, 4, 145 - 148
Janneke Ruinemans-Koerts, Monique van Uum-Otters, Don van Baar, Joost van Neerven, Judit Wesseling
[DOI No.: https://doi.org/10.33696/immunology.4.143]
Commentary
Manufacturing of Human T-lymphoid Progenitors from Two Different Hematopoietic Stem Cell Sources and Perspective for New Immunotherapies
J Cell Immunol, 2022, 4, 149 - 157
Pierre Gaudeaux, Ranjita Devi Moirangthem, Pauline Rault, Hanem Sadek, Francesco Carbone, Marieke Lavaert, Akshay Joshi, Tom Taghon, Isabelle André, Olivier Nègre, Tayebeh-Shabi Soheili